The geography of antidepressant, antipsychotic, and stimulant utilization in the United States

"Using a multilevel model, we find that access to health care, insurance coverage and pharmaceutical marketing efforts explain much of the geographic variation in use."

http://www.ncbi.nlm.nih.gov/pubmed/23357544